New Photonic Effect Could Speed Drug Development
Twisted semiconductor nanostructures convert red light into twisted blue light in tiny volumes
Drug Development
Screening Billions of Chemical Compounds to Find Effective New Drug Therapies
Researchers demonstrate “V-SYNTHES,” a virtual method of sifting through “molecular puzzle pieces”
Corralling the Costs of R&D
How unmasking asset utilization unlocks ROI
A Tool to Interrogate a New Class of Drugs
Scientists use a technique called “targetable reactive electrophiles and oxidants,” or T-REX for short, to study reactive electrophiles
Experts Raise Questions about Current Standards of Drug Regulation
Surrogate endpoints provide no guarantee of clinical benefit and should be used only as a last resort in drug trials
How ELNs Can Help to Drive Innovation in Life Sciences
Electronic lab notebooks have the potential to significantly improve data management issues in biopharmaceutical development
Drug Researchers Tackle the Malaria Parasite at Multiple Life Stages
Researchers begin further testing of two inexpensive and effective antimalarial drug candidates
Transforming Biologic Drug Development
Making simultaneous CE-SDS/CIEF analyses of multiple samples possible
Existing Drug Is Shown to Inhibit Virus That Causes COVID-19
Scientists have found that the drug masitinib may be effective in treating COVID-19
Key Aspects of Regulatory Approval for New Drugs
In this Q&A, Francisco Polidoro, Junior, PhD, discusses the basics of the drug review and approval process, current challenges, and areas for improvement